Skip to content

"Salivary Melatonin and Cortisol Levels in Individuals with Bruxism"

The Investigation of Melatonin and Cortisol Levels in the Saliva of Individuals with Bruxism

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06623643
Enrollment
100
Registered
2024-10-02
Start date
2024-10-30
Completion date
2025-02-28
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bruxism

Keywords

melatonin, saliva, cortizol

Brief summary

The effects of the hormones melatonin and cortisol, which play a highly effective role in regulating the sleep-wake cycle, on teeth grinding will be scientifically evaluated. Based on the research results, more effective methods for treating patients suffering from bruxism may be identified.

Interventions

DIAGNOSTIC_TESTThe investigation of melatonin and cortisol levels in the saliva

In the related study, patient data from individuals who visited the Oral and Maxillofacial Radiology clinic at Van Yüzüncü Yıl University Faculty of Dentistry with complaints of bruxism will be used. The diagnosis of bruxism will be made based on clinical data. Diagnoses will be made by Dr. Sema KAYA using clinical findings such as patient history used for the current diagnosis of bruxism, tooth wear, tooth mobility, pain in the temporomandibular joint (TMJ), headaches, pain in the chewing muscles, hypertrophy, and a feeling of fatigue. Before taking the saliva samples, patients will be asked to rinse their mouths with sterile water, and then they will be asked to spit into sterile plastic containers. After approximately 3 mL of saliva is collected, it will be transferred to appropriate Eppendorf tubes and stored at -80°C. Melatonin and cortisol levels will later be analyzed using the enzyme-linked immunosorbent assay (ELISA) method.

Sponsors

Yuzuncu Yil University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Individuals without any known hormonal diseases, not using antidepressants or medications that could alter saliva content, without degenerative diseases affecting the salivary glands, without cysts or tumors affecting the temporomandibular region, and not undergoing insomnia treatment will be included in the study

Exclusion criteria

* Individuals with systemic diseases that affect or may potentially affect saliva content, or those using medications that cause these effects, will not be included in the study

Design outcomes

Primary

MeasureTime frameDescription
levels of melatoninBaseline assessment at the start of the study, follow-up assessments at 3 months and 6 months, with final data collection at 12 months.individuals with bruxism
levels of cortisolBaseline assessment at the start of the study, follow-up assessments at 3 months and 6 months, with final data collection at 12 months.individuals with bruxism

Contacts

Primary ContactSema Kaya
semakaya@yyu.edu.tr+90 432 225 17 22

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026